当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 利润表

益佰制药

(600594)

  

流通市值:24.32亿  总市值:24.32亿
流通股本:7.84亿   总股本:7.84亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入989,980,001.03689,387,704.62358,837,040.951,862,920,853.13
  营业收入989,980,001.03689,387,704.62358,837,040.951,862,920,853.13
二、营业总成本1,110,706,131.69742,482,846.67374,652,779.962,001,366,895.95
  营业成本453,179,641.15291,849,727.86150,985,925.19751,460,808.48
  税金及附加21,185,710.8514,456,229.868,511,918.6931,457,220.29
  销售费用381,877,248.46270,860,570.2137,626,547.14822,931,542.08
  管理费用198,379,278.97123,090,573.7758,623,429.15290,532,433.13
  研发费用40,229,637.5131,516,868.2513,469,997.1884,269,082.59
  财务费用15,854,614.7510,708,876.735,434,962.6120,715,809.38
  其中:利息费用16,866,612.7511,382,355.035,691,450.1423,374,518.45
  其中:利息收入1,605,391.541,068,361.22485,260.483,767,249.28
三、其他经营收益
  加:投资收益46,795.14-80,051.75-5,196.72-214,599.61
  资产处置收益1,774,022.191,827,269.371,836,628.72-27,210,380.43
  资产减值损失(新)-34,815,168.83-30,578,373.02-12,212,528.62-159,485,265.14
  信用减值损失(新)288,333.69288,333.6947,826.78-2,794,771.52
  其他收益11,294,956.497,451,488.124,244,601.7824,168,885.77
四、营业利润-142,137,191.98-74,186,475.64-21,904,407.07-303,982,173.75
  加:营业外收入4,293,295.343,011,527.741,363,626.274,710,784.35
  减:营业外支出3,591,213.771,897,716.12334,699.812,476,946.3
五、利润总额-141,435,110.41-73,072,664.02-20,875,480.6-311,748,335.7
  减:所得税费用6,802,353.395,387,915.878,087,807.4423,593,549.41
六、净利润-148,237,463.8-78,460,579.89-28,963,288.04-335,341,885.11
(一)按经营持续性分类
  持续经营净利润-148,237,463.8-78,460,579.89-28,963,288.04-335,341,885.11
(二)按所有权归属分类
  归属于母公司股东的净利润-151,250,491.81-80,337,813.1-29,524,902.89-329,562,325.95
  少数股东损益3,013,028.011,877,233.21561,614.85-5,779,559.16
  扣除非经常损益后的净利润-162,517,142.91-87,454,282.99-34,801,324.57-325,096,335.78
七、每股收益
  (一)基本每股收益-0.19-0.1-0.04-0.42
  (二)稀释每股收益-0.19-0.1-0.04-0.42
八、其他综合收益-5,227.47,181.75--164,440.9
  归属于母公司股东的其他综合收益-5,227.47,181.75--164,440.9
九、综合收益总额-148,242,691.2-78,453,398.14-28,963,288.04-335,506,326.01
  归属于母公司股东的综合收益总额-151,255,719.21-80,330,631.35-29,524,902.89-329,726,766.85
  归属于少数股东的综合收益总额3,013,028.011,877,233.21561,614.85-5,779,559.16
公告日期2026-10-312026-08-212026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑